CD19 and acute lymphoblastic leukemia: In this work, we combine B-ALL patient data with high-throughput mutagenesis, mathematical modelling and RBP knockdowns to comprehensively characterise cis-regulatory mutations and trans-acting RBPs controlling CD19 exon 2 splicing.